Corvus Pharmaceuticals Inc

NASDAQ:CRVS  
2.91
-0.03 (-1.02%)
Earnings Announcements

Corvus Pharmaceuticals Provides Business Update And Reports First Quarter 2021 Financial Results

Published: 04/29/2021 20:33 GMT
Corvus Pharmaceuticals Inc (CRVS) - Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results.
Corvus Pharmaceuticals Inc - As of March 31, 2021, Corvus Had Cash, Cash Equivalents and Marketable Securities Totaling $68.0 Million.
Corvus Pharmaceuticals Inc - Net Loss for Three Months Ended March 31, 2021 Was $11.6 Million Compared to a Net Loss of $12.9 Million for Same Period in 2020.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.34

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.38

More details on our Analysts Page.